Decoding the Future of Translational Research at the Biomarker and Companion Diagnostics Conference - Frankfurt, Germany, October 5-6th 2023

News provided by

Sep 28, 2023, 14:15 ET

DUBLIN, Sept. 28, 2023 /PRNewswire/ -- The "Biomarker and Companion Diagnostics Conference" conference has been added to ResearchAndMarkets.com's offering.

This groundbreaking event is positioned to shed light on the evolving dynamics of biomarker research and its intersection with precision medicine.

Championing this initiative, the conference convenes thought leaders from premier global pharmaceutical entities, pioneering biotech ventures, and esteemed academic institutions, spanning varied therapeutic domains and drug development phases.

At the heart of the conference lies a focus on the integration of biomarkers in drug discovery, as well as the critical realm of cancer biomarkers. Our distinguished panel of experts will journey through pivotal discussions around challenges, innovations, and methodologies in the Clinical Applications of Biomarkers, covering sectors like Immuno-Oncology, Neurology, and Inflammatory Diseases. Attendees are poised to gain invaluable insights through real-world case studies, offering a roadmap for revenue generation and a deep dive into the clinical translation nuances of biomarkers.

Conference Highlights:

Unravelling the Pathways to Commercialization of CDx.
Exploration of Proteomics and Genomics-driven Biomarkers.
Biomarker Drug Discovery and Advanced Assay Development.
Delving into Multiplex Companion Diagnostics and Navigating Regulatory Mandates.
Strategies for Clinical Trials Design in CDx.
Digital Biomarkers, Predictive Markers, Precision Medicine, and the World of Big Data.

Why Make This Your Must-Attend Event?

Engage with the vanguard of the industry and academia in biomarkers, translational medicine, and diagnostics.
Uncover the seamless integration of biomarkers in drug development, encapsulating sectors like immuno-oncology, neuroscience, and more.
Extract novel insights on pioneering biomarkers for multifaceted applications.
Deep dive into case studies on state-of-the-art tech innovations in areas like digital pathology, AI, and more.
Leverage unparalleled networking prospects. This two-day congress is a melting pot of intense scientific and business dialogues, bolstered by curated 1-2-1 meetings.

Calling On: Research aficionados, clinicians, academicians, and professionals from pharmaceutical, biopharma realms, and esteemed academic circles, especially those anchored in:

Biomarker Discovery/Development
Clinical Biomarker Dynamics
Imaging Biomarkers & Pathology
Proteomics Biomarkers & Experimental Medicine
Personalized Medicine & Immunology Biomarkers

For a detailed itinerary, visit https://www.researchandmarkets.com/r/183i4b

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets